Autologous Antigen-activated Dendritic Cells in the Treatment of Patients With Breast Cancer

Summary

The purpose of this work: to assess the tolerability and effectiveness of the autogemotherapy method on the basis of autologous antigen-activated dendritic cells in the treatment of patients with breast cancer. This technology is intended for complex treatment of patients with breast cancer and is aimed at preventing the occurrence and treatment of secondary foci. The need for this technology is justified by the widespread occurrence of breast cancer among women, a decrease in the average age at onset of the disease and a young age, and the chemoresistantness of locally advanced forms of cancer.

Timeline

Start

2014-02-11

Primary completion

2017-02-11

Completion

2017-09-11

Drugs

Indications